Nature Foods for the Treatment of Nonalcoholic Fatty Liver Disease

被引:2
|
作者
Sun, Mengxia [1 ]
Ye, Hua [1 ,2 ]
机构
[1] Ningbo Univ, Affiliated Lihuili Hosp, Ningbo, Peoples R China
[2] Ningbo Univ, Affiliated Lihuili Hosp, Ningbo 315040, Peoples R China
关键词
mechanism; NAFLD; nature food; therapy; DIET-INDUCED OBESITY; LYCIUM-BARBARUM; HEPATIC STEATOSIS; CHLOROGENIC ACID; OXIDATIVE STRESS; GENE-EXPRESSION; LIPID PROFILE; DOUBLE-BLIND; HEPG2; CELLS; PPAR-GAMMA;
D O I
10.1089/jmf.2022.K.0052
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Nonalcoholic fatty liver disease (NAFLD) is one of the most common chronic liver diseases worldwide. The etiology of NAFLD is highly heterogeneous, which occurs and develops under the joint action of metabolism, inflammation, genetics, environment, and gut microbiota. At present, the principal therapeutic modalities targeting NAFLD are lifestyle interventions such as weight loss through diet and exercise. At present, there is no established therapy for the treatment of NAFLD, and many therapies are associated with a variety of side effects. A great number of in vitro and in vivo experiments have indicated that there are many natural foods that have therapeutic potential for NAFLD. This review summarizes the natural foods and their mechanisms that were found in recent years, furthermore, provides further information relevant to the treatment of NAFLD.
引用
收藏
页码:1 / 13
页数:13
相关论文
共 50 条
  • [31] Current treatment options for nonalcoholic fatty liver disease
    Shetty, Akshay
    Syn, Wing-Kin
    CURRENT OPINION IN GASTROENTEROLOGY, 2019, 35 (03) : 168 - 176
  • [32] The pharmacological treatment of nonalcoholic fatty liver disease in children
    Crudele, Annalisa
    Panera, Nadia
    Braghini, Maria Rita
    Balsano, Clara
    Alisi, Anna
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2020, 13 (11) : 1219 - 1227
  • [33] The treatment of nonalcoholic fatty liver disease with metformin and lactulose
    Meparidze, M.
    Kipshidze, N. N.
    Kodua, T.
    Jebashvili, M.
    Kakauridze, N.
    Khelashvili, M.
    Mosistrapishvili, M.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 410 - 410
  • [34] Evaluation of Statin Treatment for Nonalcoholic Fatty Liver Disease
    Newsome, Jonathan S.
    JOURNAL OF PHARMACY TECHNOLOGY, 2016, 32 (04) : 169 - 173
  • [35] Advances in the Understanding and Treatment of Nonalcoholic Fatty Liver Disease
    Stephen A. Harrison
    Adrian M. Di Bisceglie
    Drugs, 2003, 63 : 2379 - 2394
  • [36] Review of Treatment Options for Nonalcoholic Fatty Liver Disease
    Corrado, Richele L.
    Torres, Dawn M.
    Harrison, Stephen A.
    MEDICAL CLINICS OF NORTH AMERICA, 2014, 98 (01) : 55 - +
  • [37] Nonalcoholic Fatty Liver Disease Is Related to Nonalcoholic Fatty Pancreas Disease
    van Geenen, Erwin-Jan M.
    Smits, Mark M.
    Schreuder, Tim C. M. A.
    van der Peet, Donald L.
    Bloemena, Elisabeth
    Mulder, Chris J. J.
    PANCREAS, 2010, 39 (08) : 1185 - 1190
  • [38] Nonalcoholic fatty liver disease
    Alfie, ME
    Treem, WR
    PEDIATRIC ANNALS, 2006, 35 (04): : 290 - +
  • [39] Nonalcoholic fatty liver disease
    Bayard, Max
    Holt, Jim
    Boroughs, Eileen
    AMERICAN FAMILY PHYSICIAN, 2006, 73 (11) : 1961 - 1968
  • [40] Nonalcoholic fatty liver disease
    Clark, JM
    Brancati, FL
    Diehl, AM
    GASTROENTEROLOGY, 2002, 122 (06) : 1649 - 1657